Advertisement
Advertisement
RIGL
Rigel Pharmaceuticals Inc. (New)
48.13
USDSponsored
-0.69
-1.41%
Sep 23, 16:00 UTC -4
Closed
After-Market
49.12
+0.99
+2.06%
Rigel Pharmaceuticals Inc. (New) Financial Snapshot
| Market Cap | 917.55M |
| Beta | 1.20 |
| Earnings Per Share (EPS) | 16.32 |
| Price-to-Book (P/B) Ratio | 2.05 |
| Operating Margin | 27.66% |
| Total Debt/Equity (D/E) | 9.22% |
| P/E Ratio | 12.01 |
| Return on Equity (ROE) | 22.95% |
| Current Ratio | 1.94% |
| Free Cash Flow | 33.38M |
